Diskussionsleiter: U. Kintscher (Berlin), R. Schulz (Gießen), M. Kreußer (Heidelberg)
| (P1395) | Disruption of oxidative PKA activation prevents Ang II-dependent hypertrophy | |
| T. Islam, C. Dantz, H. Daniel, H. Moellencamp, A. El-Armouche, P. Eaton, L. S. Maier, S. Wagner (Göttingen, Dresden, Regensburg; London, UK) | ||
| (P1396) | The tumor suppressor gene TIP30 impedes pressure overload induced cardiac hypertrophy by inhibiting the translational machinery. | |
| A. Grund, M. Szaroszyk, M. Korf-Klingebiel, C. Tiedje, M. Gaestel, S. Batkai, T. Thum, K. C. Wollert, X. Yin, M. Mayr, A. Pich, H. A. Katus, O. J. Müller, J. Bauersachs, J. Heineke (Hannover, Heidelberg; London, UK) | ||
| (P1397) | AAV9-shRNA mediated ablation of the calcineurin-binding protein CIB1 in the mouse myocardium inhibits pressure-overload induced cardiac hypertrophy. | |
| A. Grund, J. Döppner, M. Szaroszyk, O. J. Müller, H. A. Katus, M. Korf-Klingebiel, T. Thum, K. C. Wollert, J. Bauersachs, J. Heineke (Hannover, Heidelberg) | ||
| (P1398) | Identification of differentially regulated long non-coding RNAs in cardiac hypertrophy | |
| C. Kuhn, F. Dierck, S. Hille, N. Frey (Kiel) | ||
| (P1399) | Impaired cardiac function in MMP13 knock out mice | |
| D. Lindner, P. M. Becher, S. Lämmle, F. Gotzhein, H. Schotola, S. T. Sossalla, A. El-Armouche, S. Blankenberg, D. Westermann (Hamburg, Dresden, Göttingen) | ||
| (P1400) | Kardiomyozytäre Transgen-Expression von TBC1D10C erhöht die LVEF, Leistungsfähigkeit und Lebenserwartung in der Maus. | |
| C. Volland, S. Bremer, K. Toischer, M. Didié, K. Hellenkamp, N. Dybkova, S. Sosalla, D. Liebetanz, B. Unsöld, G. Hasenfuß, T. Seidler (Göttingen) | ||
| (P1401) | The prohypertrophic molecule Dyxin/Lmcd1 is regulated by the stress-responsive transcription factor MEF2 | |
| F. Eilers, R. Frauen, B. Johnson, E. N. Olson, N. Frey, D. Frank (Kiel; Berkeley, Dallas, US) | ||
| (P1402) | Cardiomyopathy-associated protein 5 is a novel interaction partner for four and a half LIM domains protein 2 in cardiac myocytes | |
| J. Schnittger, N. Mangels, A. Piasecki, J. Findlay, G. Baillie, K. Stathopoulou, F. Cuello (Hamburg; Glasgow, UK) | ||
| (P1403) | CTRP9 induces eccentric hypertrophy under pathological cardiac pressure overload | |
| M. Appari, A. Breitbart, F. Brandes, M. Szaroszyk, M. Korf-Klingebiel, H. Wang, N. Froese, D. Fraccarollo, U. Schrameck, H. A. Katus, K. C. Wollert, O. J. Müller, J. Bauersachs, J. Heineke (Hannover, Heidelberg) | ||
| (P1404) | Die Funktion der Histone Deacetylase 6 (HDAC6) in der Entstehung und Progression von mal-adaptiver kardialer Hypertrophie | |
| S. Brix, J. Grune, J. Salatzki, Z. Ban, V. Benz, R. Klopfleisch, U. Kintscher, A. Foryst-Ludwig (Berlin) | ||
| (P1405) | Ranolazine improves cardiac hypertrophy and contractile dysfunction in a chronic heart failure model. | |
| U. Primessnig, P. Schönleitner, A. Schmidt, A. Hoell, P. Wakula, S. Engelhardt, G. Antoons, B. Pieske, F. R. Heinzel (Graz, AT; München, Berlin) | ||
| (P1406) | Metformin Treatment Preserves Cardiac Contractility During Pressure Overload in Rats | |
| A. Schrepper, M. Schwarzer, C. Werner, T. Doenst (Jena) | ||
| (P1407) | Preferential right ventricular hypertrophy of cardiomyocytes in arrhythmogenic right ventricular cardiomyopathy patients and characterization of the hypertrophic response in a murine disease model | |
| M. Gerçek, M. Gerçek, S. Kant, A. Gärtner-Rommel, H. Milting, R. E. Leube, C. A. Krusche (Aachen, Bad Oeynhausen) |